People across the globe are waiting for the vaccine breakthrough for deadly COvid 19, for which a few of the major companies have deepened their research aspects. Companies step up with products in the pipeline, but we need to wait and see who comes first!!
Also, due to the unexpected pandemic affect the there exists the lack of test kits, however, different pharma and biotech companies, and surprisingly nonhealthcare companies have also come forward to develop the test kits which will provide the results in minutes!
datam provides a detailed executive snapshot/outlook on COvid-19 with the healthcare industry coming together to fight back COvid 19.
Disruptive Supply Chain
Virus Effect on population by age group
Companies and their efforts to treat COvid-19
Companies with their Pipelines
Healthcare Leaders fear for COvid -19
How healthcare companies fall back to normal
Pharma giants and their concern for production
Is there any impact of China pharma product post-COvid-19, globally?
Impact on healthcare infrastructure
Financial Disturbance for Pharma companies and their stock variations
Healthcare Regulatory take on their respective pharma companies and treatment possibilities
Major casualty by countries and their way to handle their downfall? Mainly – China, Italy, Spain, US, France and among others
Impact of the virus on the import and export of medical products?
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
